SUCAMPO PHARMACEUTICALS
Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of specialized medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA – and a late-stage pipeline of product candidates in clinical development for orphan disease areas. VTS-270 is a mixture of 2-hydroxypropyl-B-cyclodextrins with a specific compositional fingerprint that has been granted orphan designation in the U.S. and... Europe and is in a pivotal Phase 2/3 clinical trial for the treatment of Niemann-Pick Disease Type C-1. Sucampo has an option for the North American rights to CPP1- x/sulindac, which is in Phase 3 development for the treatment of familial adenomatous polyposis and has been granted orphan drug designation in the U.S. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan and Switzerland.
SUCAMPO PHARMACEUTICALS
Industry:
Biotechnology Health Care
Founded:
1996-01-01
Address:
Bethesda, Maryland, United States
Country:
United States
Website Url:
http://www.sucampo.com
Total Employee:
51+
Status:
Active
Contact:
3019613440
Total Funding:
300 M USD
Technology used in webpage:
Domain Not Resolving SPF IPv6 Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Microsoft IIS 10 CPanel DMARC
Similar Organizations
Curtiss Healthcare
Curtiss Healthcare is a biopharmaceutical company.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Current Employees Featured
Peter Greenleaf Chief Executive Officer @ Sucampo Pharmaceuticals
Chief Executive Officer
Peter Lichtlen Senior Medical Officer and the Vice President @ Sucampo Pharmaceuticals
Senior Medical Officer and the Vice President
2011-01-01
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-04-03 | Vtesse | Vtesse acquired by Sucampo Pharmaceuticals | N/A |
| 2015-10-31 | R-Tech Ueno | R-Tech Ueno acquired by Sucampo Pharmaceuticals | N/A |
Official Site Inspections
http://www.sucampo.com
- Host name: sucampo.com
- IP address: 146.214.96.210
- Location: St Louis United States
- Latitude: 38.6249
- Longitude: -90.4496
- Metro Code: 609
- Timezone: America/Chicago
- Postal: 63131
More informations about "Sucampo Pharmaceuticals"
Sucampo Pharmaceuticals - Craft
Sucampo Pharmaceuticals $230.06 m in annual revenue in FY 2016. See insights on Sucampo Pharmaceuticals including office locations, competitors, revenue, financials, executives, …See details»
Sucampo Pharmaceuticals Company Profile | Management and
Sucampo Pharmaceuticals Profile and History. Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing, identifying, acquiring, and marketing …See details»
Sucampo Pharmaceuticals - Crunchbase Company …
Sucampo is a biopharmaceutical company. View contacts for Sucampo Pharmaceuticals to access new leads and connect with decision-makers.See details»
Sucampo - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 1, 2025 Sucampo is a global biopharmaceutical company focused on research and development of proprietary drugs based on prostones, to treat gastrointestinal, ophthalmic and …See details»
Overview, News & Similar companies - ZoomInfo.com
Feb 6, 2018 On December 26, 2017, the Company, a leading global specialty pharmaceutical organization, entered into an agr. Dec 28, 2017. www.accesswire.com . Mallinckrodt To …See details»
Sucampo Pharmaceuticals, Inc. Information - RocketReach
What is the annual revenue of Sucampo Pharmaceuticals, Inc.? The Sucampo Pharmaceuticals, Inc. annual revenue was $230.1 million in 2024.See details»
Sucampo Company Profile 2025: Valuation, Investors, Acquisition
Sucampo General Information Description. Manufacturer of pharmaceuticals and health care products. The company engages in developing of Amitiza and all other prostone compounds.See details»
Sucampo Pharmaceuticals Inc financial reports 2025 - ReadyRatios
Sep 30, 2017 Business Address: 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE, MD 20850: State of Incorp. Fiscal Year End: December 31: Industry (SIC) 2834 - Pharmaceutical …See details»
Sucampo Pharma Americas, LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Sucampo Pharma Americas, LLC of Bridgewater, NJ. Get the latest business insights from Dun & …See details»
Sucampo Pharmeceuticals - Overview, News & Competitors
Sucampo Pharmeceuticals. Consumer Services · Maryland, United States · <25 Employees. Sucampo Pharmeceuticals is a company that operates in the Pharmaceuticals industry.See details»
Organization | Sucampo
Organization Overview. First Clinical Trial. 2005 NCT00380250. First Marketed Drug. 2000 unoprostone isopropyl . First NDA Approval. 2006 lubiprostone . Last Known Activity. 2017 …See details»
Sucampo | Mallinckrodt Pharmaceuticals
Sucampo is now a part of Mallinckrodt. On February 13, 2018, Mallinckrodt closed on our acquisition of Sucampo Pharmaceuticals, Inc. Full details are available in the press release …See details»
Sucampo’s Competitors, Revenue, Number of Employees, Funding …
Sucampo’s Profile, Revenue and Employees. Sucampo develops and commercializes therapeutic compounds for the treatment of genetic disorders and orphan diseases. Sucampo’s primary …See details»
Sucampo Pharmaceuticals - PitchBook
Sucampo Pharmaceuticals General Information Description. Manufacturer and developer of specialized medicines. The company focuses on the development and commercialization of …See details»
SUCAMPO PHARMA LIMITED LIABILITY COMPANY - Dun
Find company research, competitor information, contact details & financial data for SUCAMPO PHARMA LIMITED LIABILITY COMPANY of CHIYODA-KU, TOKYO. Get the latest business …See details»
Sucampo Pharmaceuticals - Contacts, Employees, Board Members, …
Sucampo is a biopharmaceutical company. AI Content may contain mistakes and is not legal, financial or investment advice.See details»
Sucampo Pharma Americas - Overview, News & Similar companies …
Sucampo Pharma Americas LLC is a company that operates in the Pharmaceuticals industry. It employs 11-20 people and has $5M-$10M of revenue. The company is headquartered in …See details»
Mallinckrodt concludes Sucampo Pharma acquisition for $1.2bn
Feb 15, 2018 Mallinckrodt concludes Sucampo Pharma acquisition for $1.2bn. Mallinckrodt has completed its previously announced acquisition of biopharmaceutical firm Sucampo …See details»
Sucampo Pharma Americas, LLC Careers and Employment
Find out what works well at Sucampo Pharma Americas, LLC from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for …See details»
Sucampo Aims To Be More Than Just A One-Drug Wonder
Oct 14, 2015 Biotech Sucampo Pharmaceuticals has had a mostly good year, but it's preparing for a challenging future. Sucampo has enjoyed strong sales and profit growth over the past …See details»